How a patent dispute with 10x helped decimate NanoString’s stock price
Recent $31 million damages award has dealt a further blow to the company's faltering share value
Recent $31 million damages award has dealt a further blow to the company's faltering share value
The latest AST Patent Deals Report shows assets being transacted by the likes of Huawei and Intel on the sell side, and Philips and Softbank on the buy side
Long Read: As all signs point towards a fresh surge of biosimilars litigation, experts from Goodwin Procter and Gemini Law analyse the previous tranche of disputes to tease out the strategies that can still be useful to rights holders
31 May 2023
Almost 50 cases have arisen in which IP owners are asserting their rights to an extended timeframe, the outcomes of which will have major ramifications in Latin America’s largest economy
30 May 2023
The diagnostics innovator has bagged a further $100 million in damages, but the country’s patent system has put unnecessary hurdles in the way, argues representative John Desmarais.
25 May 2023
Pharma companies in India are struggling to enforce compounds that are covered by both genus and subsequent species patents. While the latest case involved a series of injunctions being vacated, the patent community is still unsatisfied by the lack of concrete judgments on this issue.
24 May 2023
The ruling by the US Court of Appeals for the Federal Circuit limits analogous art, and innovators can leverage this precedent by adopting certain patent drafting methods
23 May 2023
The Supreme Court yesterday handed down one of the most anticipated patent decisions in decades
19 May 2023
But there’s no clarity yet on the new section’s competencies
19 May 2023
The Munich Regional Court has also granted a permanent injunction against NanoString Technologies
18 May 2023
The decision, leaving in place a polarising Federal Circuit decision, has significant implications for life sciences IP strategies
16 May 2023
Opinion: Pharma and biotech patent professionals must adapt to new challenges and opportunities
13 May 2023
Unlock unlimited access to all IAM content